Memory Pharmaceuticals Corp (MEMY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

100 PHILIPS PARKWAY MONTVALE, NJ 07645

Focuses on the discovery and development of drug candidates for the treatment of a broad range of central nervous system (CNS) conditions that exhibit significant impairment of memory and other cognitive functions. These conditions include Alzheimer's disease, schizophrenia and depression.

View SEC Filings from MEMY instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MEMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MEMY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GILBERT WALTER PHD

  • Director
No longer subject to file 2009-01-05 0

YOUNG PETER

  • Director
No longer subject to file 2009-01-05 0

BLAKE PAUL

  • Director
No longer subject to file 2009-01-05 0

EVNIN ANTHONY B

  • Director
0 2009-01-05 0

GREAT POINT PARTNERS LLC

JAY JEFFREY R

KROIN DAVID

  • 10% Owner
No longer subject to file 2009-01-05 0

KRIEBEL ROBERT I

  • Director
No longer subject to file 2009-01-01 0

MEYERS MICHAEL E

  • Director
No longer subject to file 2009-01-01 0

FLEMING JONATHAN

  • Director
No longer subject to file 2009-01-01 0

SULAT JAMES R

  • Director
No longer subject to file 2009-01-01 0

LALANI JZANEEN GENERAL COUNSEL

  • Officer
0 2009-01-01 0

MURRAY STEPHEN R CHIEF MEDICAL OFFICER

  • Officer
0 2009-01-01 0

SMITH MICHAEL P CHIEF FINANCIAL OFFICER

  • Officer
0 2009-01-01 0

LOWE DAVID A CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2009-01-01 0

MPM BIOVENTURES IV QP LP

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

  • 10% Owner
0 2009-01-01 0

KAILIAN VAUGHN M

GADICKE ANSBERT

EVNIN LUKE

ST PETER STEVEN

GREENE WILLIAM

SCOPA JAMES PAUL

DOMBKOWSKI ASHLEY L

VANDER VORT JOHN

  • Director
  • 10% Owner
0 2009-01-01 0

STANLEY MEDICAL RESEARCH INSTITUTE

  • 10% Owner
9,724,931 2008-08-25 0

KAILIAN VAUGHN M PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
0 2008-02-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments